Optimizing glycemic control: clinical utility of exenatide prolonged release injection
نویسندگان
چکیده
منابع مشابه
A Review of Exenatide: Optimizing Glycemic Control and Associated Cardiovascular Risk Factors in Type 2 Diabetes
Type 2 diabetes mellitus (T2DM) is a well-recognized risk factor for the development of cardiovascular disease. With an increasing prevalence of obesity, this risk has increased further. Management of T2DM in obese patients is particularly challenging as treatment with the majority of glucose-lowering agents results in weight gain. Thus, the development of a therapeutic option which could impro...
متن کامل[Retrobulbar triamcinolone injection and glycemic control].
OBJECTIVE To look for alterations of glycemic control as a secondary systemic effect of the retrobulbar injection of triamcinolone acetonide in diabetic and non-diabetic patients. MATERIALS AND METHODS We studied 40 patients (25 men and 15 women, 20 with and 20 without diabetes). The injection site in all patients was the retrobulbar space, with one injection of 1ml triamcinolone acetonide (4...
متن کاملLithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations
Lithium has been a gold standard in the treatment of bipolar disorder (BD) for several decades. Despite a general reduction in the use of lithium over the past several years, it is effective in the management of both manic and depressive episodes in BD and continues to be recommended as a first-line mood stabilizer. This review provides an overview of the pharmacology of lithium and highlights ...
متن کاملExenatide extended-release; clinical trials, patient preference, and economic considerations
Type 2 diabetes remains an escalating problem worldwide, despite a range of treatments being available. The revelation that insulin secretion is under the control of a gut hormone, glucagon-like peptide 1, has led to a new paradigm in the management of type 2 diabetes, ie, use of medicines that directly stimulate or prolong the actions of endogenous glucagon-like peptide 1 at its receptors. Exe...
متن کاملMethodological Issues on a Clinical Trial to Test Tapentadol Prolonged release vs. Oxycodone/Naloxone Prolonged release
To the Editor: A recent article by Baron et al. reports the results of a clinical trial (CT) to compare the effectiveness of tapentadol with oxycodone/ naloxone (Ox/Nal) for the treatment of chronic low back pain of neuropathic origin. This study is a remarkable attempt to progress in this area. We argue, however, that it contains several drawbacks that leave open ground for further trials with...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Research and Reports in Endocrine Disorders
سال: 2012
ISSN: 2230-2271
DOI: 10.2147/rred.s24237